Sub menu

 
 

Update to listed medicine ingredients in October 2021

Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2021
Published

Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2021, which commenced on 25 October 2021. This determination replaces the previous instrument, the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2021.

This instrument is updated frequently and there may be a more recent version of the instrument. Ensure you are accessing the current version of the instrument through the Therapeutic Goods Determination page.

A complete list of the 13 changed ingredients is below.

Changed ingredients

Substance nameChange
3'-sialyllactose sodiumAddition
4-(para-hydroxyphenyl)-2-butanoneChange
6'-sialyllactose sodiumAddition
Bacillus coagulansChange
Change of name from cedarwood oil atlas to Cedrus atlantica wood oilChange
Change of name from raspberry essence to raspberry fruit extractChange
Crocus sativusChange
dihydrocapsiateAddition
epoxy cedreneRemoval
hydrolysed chicken cartilage extractAddition
sabineneAddition
skipjack-liver oilChange
sodium calcium edetateAddition
Topics
Featured in

Related content

Help us improve the Therapeutic Goods Administration site